India, Sept. 15 -- Ascendis Pharma A/S (ASND) is down 13.07 percent, losing $34.64 to $230.28 on Tuesday. The move comes after the biopharmaceutical company announced that its Board of Directors authorized a share repurchase program of upto $400 million of its ordinary shares.
Ascendis Pharma is currently trading at $230.28, down from the previous close of $264.92 after opening at $256.25 on the Nasdaq. The stock has traded between $230.18 and $257.53 during the session, with trading volume at 939,438 shares versus average volume of 656,898.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Repurchases may be conducted through open-market purchases, privately negotiated transactions, block trades, accel...